1597291-19-4 Usage
Uses
Used in Pharmaceutical Industry:
(S)-2-((R)-2-methoxypropoxy)propanoic acid is used as a key building block for the synthesis of various pharmaceuticals. Its unique chiral structure allows for the creation of complex molecules with specific biological activities, contributing to the development of new drugs with improved efficacy and selectivity.
Used in Agrochemical Industry:
In the agrochemical industry, (S)-2-((R)-2-methoxypropoxy)propanoic acid is utilized as a fundamental component in the synthesis of agrochemicals. Its optical activity and structural diversity enable the production of targeted compounds with specific pesticidal, herbicidal, or fungicidal properties, enhancing crop protection and yield.
Used in Fine Chemicals Synthesis:
(S)-2-((R)-2-methoxypropoxy)propanoic acid is employed as a versatile building block in the synthesis of fine chemicals. Its chiral nature and functional groups facilitate the creation of a wide range of specialty chemicals with applications in various industries, such as fragrances, dyes, and advanced materials.
Used in Chemical Research:
(S)-2-((R)-2-methoxypropoxy)propanoic acid serves as an important compound in chemical research, particularly in the study of stereochemistry and asymmetric synthesis. Its optical activity and unique structural features make it an ideal candidate for investigating the effects of chirality on chemical reactivity and developing novel synthetic methodologies.
Check Digit Verification of cas no
The CAS Registry Mumber 1597291-19-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,9,7,2,9 and 1 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1597291-19:
(9*1)+(8*5)+(7*9)+(6*7)+(5*2)+(4*9)+(3*1)+(2*1)+(1*9)=214
214 % 10 = 4
So 1597291-19-4 is a valid CAS Registry Number.
1597291-19-4Relevant articles and documents
NOVEL PYRAZOLO PYRIMIDINE DERIVATIVES AND THEIR USE AS MALT1 INHIBITORS
-
Page/Page column 41; 42, (2015/12/31)
The present invention describes new pyrazolo-pyrimidine derivatives of formula (I) or a pharmaceutically acceptable salt thereof; (I) wherein, R1 is halogen, cyano, or C1-C3alkyl optionally substituted by halogen; R2 is C1-C6alkyl optionally substituted one or more times by C1-C6alkyl, C2-C6alkenyl, hydroxyl, N,N-di-C1-C6alkyl amino, N-mono-C1-C6alkyl amino, O-Rg, Rg, phenyl, or by C1-C6alkoxy wherein said alkoxy again may optionally be substituted by C1-C6alkoxy, N,N-di-C1-C6alkyl amino, Rg or phenyl; C3-C6cycloalkyl optionally substituted by C1-C6alkyl, N,N-di-C1-C6alkyl amino or C1-C6alkoxy-C1-C6alkyl, and/or two of said optional substituents together with the atoms to which they are bound may form an annulated or spirocyclic 4 - 6 membered saturated heterocyclic ring comprising 1 - 2 O atoms; phenyl optionally substituted by C1-C6alkoxy; a 5 - 6 membered heteroaryl ring having 1 to 3 heteroatoms selected from N and O said ring being optionally substituted by C1-C6alkyl which may be optionally substituted by amino or hydroxy; Rg; or N,N-di-C1-C6alkyl amino carbonyl; and R is phenyl independently substituted two or more times by Ra, 2-pyridyl independently substituted one or more times by Rb, 3-pyridyl independently substituted one or more times by Rc, or 4-pyridyl independently substituted one or more times by Rd; which are generally interacting with MALT1 proteolytic and/or autoproteolytic activity, and in particular which may inhibit said activity. The present invention further describes the synthesis of said new pyrazolo-pyrimidine derivatives, their use as a medicament, especially by interacting with MALT1 proteolytic and/or autoproteolytic activity.
